These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3061197)

  • 1. [Therapy of peptic ulcer. Bismuth salts].
    Börsch G
    Verh Dtsch Ges Inn Med; 1988; 94():284-92. PubMed ID: 3061197
    [No Abstract]   [Full Text] [Related]  

  • 2. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of De-Nol].
    Tomecki R; Habior A; Medrzejewski W
    Pol Tyg Lek; 1984 Sep; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 5. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM; Misra NP; Dube S
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of peptic ulcer disease.
    Ippoliti A; Peterson W
    Clin Gastroenterol; 1979 Jan; 8(1):53-67. PubMed ID: 369747
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological and clinical aspects of some drugs used in peptic ulcer treatment.
    Abrahamsson H; Dotevall G
    Scand J Gastroenterol Suppl; 1979; 55():117-20. PubMed ID: 395633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-Nol: a new concept in cytoprotection. Proceedings from an international symposium. Milan, Italy, 13 November 1985.
    Scand J Gastroenterol Suppl; 1986; 122():1-53. PubMed ID: 3465025
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of peptic ulcer.
    Barbezat GO
    N Z Med J; 1982 Nov; 95(720):813-4. PubMed ID: 6961321
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth compounds in the treatment of peptic ulcer: a review.
    Nanivadekar SA
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():736-42. PubMed ID: 2092031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Selective and locally-acting drugs in the treatment of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer drugs in the treatment of peptic ulcer.
    Tandon BN
    Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.